Elucidating disease-relevant immune cell subsets in pediatric-onset multiple sclerosis: A unique window into early disease mechanisms

阐明儿科发病的多发性硬化症中与疾病相关的免疫细胞亚群：了解早期疾病机制的独特窗口

• 批准号: 318316
• 负责人: Mexhitaj Ina
• 金额: $ 10.93万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-11-01 至 2017-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=318316&lang=en
• 关键词: Ads-Mono; Ads-Ms; Antigen-Specific Therapies; Cns Injury; Demyelination; Multiple Sclerosis; Pediatric Cohort; T Lymphocytes

Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), in which immune cells damage the covering of nerve cells in the brain and spinal cord, often leading to both physical and mental disability. Although available therapi

多发性硬化症（MS）是中枢神经系统（CNS）的炎性疾病，其中免疫细胞破坏脑和脊髓中神经细胞的覆盖，通常导致身体和精神残疾。虽然可用的治疗